Biomarkers of Alzheimer’s disease: a hope for early diagnosis

Biomarkers of Alzheimer’s disease: a hope for early diagnosis

This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2019.

Bibliografske podrobnosti
Glavni avtor:	Aziz, Farhin
Drugi avtorji:	Akter, Raushanara
Format:	Project report
Jezik:	English
Izdano:	Brac University 2019
Teme:	Biomarkers of Alzheimer’s disease Specific biomarkers Non-invasive diagnosis Amyloid-β Tau-protein aggregates Alzheimer's disease > Molecular aspects
Online dostop:	http://hdl.handle.net/10361/12804

Podobne knjige/članki

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
od: Saha, Bithi Rani
Izdano: (2023)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
od: Halim, Rabea
Izdano: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
od: Aana, Afsara Sumon
Izdano: (2021)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
od: Afra, Sumaiya
Izdano: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
od: Ferdous, Labiba
Izdano: (2023)

Role of protein’s and future treatment options for Alzheimer’s Disease
od: Islam, Md. Irfath
Izdano: (2023)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
od: Hassan, Md. Muhtaz
Izdano: (2020)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
od: Chowdhury, Sariya Uzrat
Izdano: (2022)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
od: Tasneem, Sadia
Izdano: (2021)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
od: Alim, Abdul
Izdano: (2023)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
od: Tabassum, Nadira
Izdano: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
od: Shehab, Habibul Mohsin
Izdano: (2024)

Biomarkers in the diagnosis and treatment of Covid-19
od: Kabir, Syeda Shuvessa
Izdano: (2023)

A study on less explored plants with potential neuroprotective activity against neurodegenerative diseases
od: Nayeem, Abdullah Al
Izdano: (2021)

Alzheimer's disease and marriage : an intimate account /
od: Wright, Lore K.
Izdano: (1993)

Gastrointestinal and metabolic system biomarkers in autism: a review
od: Roy, Shpona
Izdano: (2021)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
od: Ishrat, Nowshin
Izdano: (2024)

Implications of unusual non-coding RNAs in human diseases
od: Ahmed, Tazkia
Izdano: (2021)

Emerging therapies of Alzheimer’s disease: a comprehensive review
od: Tasin, Md Abtahi
Izdano: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
od: Karmaker, Swastika
Izdano: (2024)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
od: Tamanna, Mst. Taskia
Izdano: (2023)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
od: Key, Nasrin Sultana
Izdano: (2023)

Marine compounds in the treatment of Alzheimer’s disease
od: Parveen, Sanjana
Izdano: (2022)

Role of circular RNA in neurological disease
od: Salsabil, Labiba
Izdano: (2024)

Exploring Alzheimer's disease prediction with XAI in various neural network models
od: Rahman, Quazi Ashikur, et al.
Izdano: (2022)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
od: Mostofa, Golam
Izdano: (2022)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
od: Mahee, Sadique Abdal
Izdano: (2024)

A review on adult neurogenesis in Alzheimer’s disease
od: Akter, Moriam
Izdano: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
od: Zaman, Rubaiyat
Izdano: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
od: Bakar, Osama Bin Abu
Izdano: (2024)

An ambient assisted living system for Alzheimer’s patients
od: Abedin, Minhajul, et al.
Izdano: (2023)

Point-of care diagnostic devices in cancer detection
od: Yasmin, Rizwana
Izdano: (2022)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
od: Jahan, Nusrat
Izdano: (2023)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
od: Roy, Aditya, et al.
Izdano: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
od: Haque, Mushfiqul
Izdano: (2019)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
od: Dey, Manashi
Izdano: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
od: Sani, Mehedi Hasan, et al.
Izdano: (2022)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
od: Mahbub, Riasat, et al.
Izdano: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
od: Alam, Badrul, et al.
Izdano: (2016)

Functional analysis of depression associated proteins: role of TRK, BDNF, CYP2B6, POLG, PICK1 Biomarkers for early detection and treatment of depression
od: Jurashe, Partha Sanjana
Izdano: (2019)